This company pioneers a new approach to allosteric drug discovery by targeting natural hotspots on proteins to create differentiated medicines. Their proprietary Smart Allostery™ platform integrates structural biology, pharmacology, chemistry, and AI to systematically identify and drug these cellular on/off switches. The resulting novel allosteric medicines are being developed to treat diseases such as cancer and autoimmune disorders.
Funding
$210M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
PBFounders
Product
Problem
Many proteins possess natural regulatory sites, or "hotspots," that are critical to their function, but traditional drug discovery methods often fail to effectively target these allosteric sites. This limitation hinders the development of novel therapeutics that can modulate protein activity in a precise and selective manner. Consequently, treatment options for diseases like cancer and autoimmune disorders remain limited.
Solution
HotSpot Therapeutics is pioneering a new approach to allosteric drug discovery by targeting natural hotspots on proteins, which act as on/off switches to modulate protein function. The company's Smart Allostery™ platform integrates structure-function analysis, cutting-edge pharmacology, tailored chemistry, and AI to systematically uncover and drug these previously inaccessible allosteric sites. By targeting these hotspots, HotSpot aims to develop differentiated medicines that offer new ways to treat cancer and autoimmune diseases. This approach allows for the creation of highly selective therapeutics that can precisely modulate protein activity, leading to improved efficacy and reduced off-target effects.
Target Audience
The primary target audience includes patients suffering from cancer and autoimmune diseases, as well as pharmaceutical companies seeking innovative drug discovery platforms and novel therapeutic candidates.
Features
- Smart Allostery™ platform integrating structure-function analysis, pharmacology, chemistry, and AI
- Systematic identification and targeting of natural hotspots on proteins
- Discovery of novel allosteric medicines for cancer and autoimmune diseases
- Development of highly selective therapeutics with improved efficacy